CDC-Authored Genomics and Precision Health Publications Database

---

Last data update: Sep 16, 2024. (Total: 6309 publications)

All Cancer Diabetes Economic Equity Environmental FHH HLBS ID Implementation ND PGx PI Rare RCH dataset

Filtered By: Select to fine-tune your search Year Journal

Records 1-9 (of 9 Records)

Query Trace: Pearce MB[original query]
Pathogenesis and transmission of genetically diverse swine-origin H3N2v influenza A viruses from multiple lineages isolated in the United States, 2011-2016. Sun X , Pulit-Penaloza JA , Belser JA , Pappas C , Pearce MB , Brock N , Zeng H , Creager HM , Zanders N , Jang Y , Tumpey TM , Davis T , Maines TR . J Virol 2018 92 (16)
Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets. Smith GE , Sun X , Bai Y , Liu YV , Massare MJ , Pearce MB , Belser JA , Maines TR , Creager HM , Glenn GM , Flyer D , Pushko P , Levine MZ , Tumpey TM . Virology 2017 509 90-97
Enhanced virulence of clade 2.3.2.1 highly pathogenic avian influenza A H5N1 viruses in ferrets Pearce MB , Pappas C , Gustin KM , Davis CT , Pantin-Jackwood MJ , Swayne DE , Maines TR , Belser JA , Tumpey TM . Virology 2016 502 114-122
Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets Houser KV , Pearce MB , Katz JM , Tumpey TM . J Virol 2013 87 (24) 13480-9
Influenza virus h5 DNA vaccination is immunogenic by intramuscular and intradermal routes in humans. Ledgerwood JE , Hu Z , Gordon IJ , Yamshchikov G , Enama ME , Plummer S , Bailer R , Pearce MB , Tumpey TM , Koup RA , Mascola JR , Nabel GJ , Graham BS . Clin Vaccine Immunol 2012 19 (11) 1792-7
Pathogenesis and transmission of swine origin A(H3N2)v influenza viruses in ferrets Pearce MB , Jayaraman A , Pappas C , Belser JA , Zeng H , Gustin KM , Maines TR , Sun X , Raman R , Cox NJ , Sasisekharan R , Katz JM , Tumpey TM . Proc Natl Acad Sci U S A 2012 109 (10) 3944-9
DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials. Ledgerwood JE , Wei CJ , Hu Z , Gordon IJ , Enama ME , Hendel CS , McTamney PM , Pearce MB , Yassine HM , Boyington JC , Bailer R , Tumpey TM , Koup RA , Mascola JR , Nabel GJ , Graham BS . Lancet Infect Dis 2011 11 (12) 916-924
Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses Price GE , Soboleski MR , Lo CY , Misplon JA , Quirion MR , Houser KV , Pearce MB , Pappas C , Tumpey TM , Epstein SL . PLoS One 2010 5 (10) e13162
5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication Ranjan P , Jayashankar L , Deyde V , Zeng H , Davis WG , Pearce MB , Bowzard JB , Hoelscher MA , Jeisy-Scott V , Wiens ME , Gangappa S , Gubareva L , Garcia-Sastre A , Katz JM , Tumpey TM , Fujita T , Sambhara S . Virol J 2010 7 (1) 102